Suppressed immune and metabolic responses to intestinal damage-associated microbial translocation in myalgic encephalomyelitis/chronic fatigue syndrome.
Uhde, Melanie, Indart, Alyssa C, Green, Peter H R et al. · Brain, behavior, & immunity - health · 2023 · DOI
Quick Summary
This study found that people with ME/CFS have a weakened immune response to bacteria that leak through a damaged gut lining, along with unusual changes in how their bodies process glucose and other nutrients. The immune system appears to be suppressed in some ways while overactive in others, and these patterns were linked to metabolic changes. These findings suggest that gut health and metabolic dysfunction may play important roles in ME/CFS symptoms.
Why It Matters
This research identifies potential biomarkers and mechanistic pathways that could improve ME/CFS diagnosis and lead to targeted treatments addressing gut health and metabolic dysfunction. Understanding how immune suppression, metabolic changes, and intestinal damage are interconnected may explain why exertion worsens symptoms and could guide development of therapies that restore normal immune and metabolic function.
Observed Findings
Suppressed acute-phase innate immune response to microbial translocation in ME/CFS patients compared to controls
Alterations in glucose and citrate metabolism associated with immunosuppression
Evidence of compromised gut epithelial integrity in ME/CFS
Enhanced compensatory antibody responses to microbial antigens
Increased IL-10 immunoregulatory response in ME/CFS patients
Inferred Conclusions
Metabolic dysfunction and immunoregulatory responses mediate suppressed innate immunity to microbial translocation in ME/CFS
Gut epithelial barrier integrity and intestinal dysbiosis contribute to systemic immunologic and metabolic abnormalities in the condition
These mechanistic pathways may underlie both baseline and exertion-related symptom manifestation in ME/CFS
Remaining Questions
Does correcting metabolic dysfunction or restoring gut barrier function improve ME/CFS symptoms and immune responses?
Which genetic, infectious, or environmental factors trigger the initial metabolic and immune dysregulation that perpetuates microbial translocation?
What This Study Does Not Prove
This study cannot establish causation—it remains unclear whether metabolic changes cause immune suppression, result from it, or are both consequences of a separate underlying process. The findings do not prove that gut damage is the primary cause of ME/CFS, nor do they demonstrate that correcting these abnormalities will relieve symptoms. The study does not establish these biomarkers as diagnostic on their own.